Trials / Completed
CompletedNCT02587403
A Comparison of Fortiva and Strattice Tissue Matrices in Complex, Ventral Hernia Repair
A Randomized, Prospective Study Comparing Fortiva™ Porcine Dermis vs. Strattice™ Reconstructive Tissue Matrix in Patients Undergoing Complex Open Primary Ventral Hernia Repair
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- RTI Surgical · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to compare the effectiveness of Fortiva Porcine Dermis versus Strattice Reconstructive Tissue Matrix for the underlay reinforcement of complex ventral hernia repair and assess post-operative complication rates, long term hernia recurrence rates.
Detailed description
This is a randomized, prospective, double-blinded study evaluating the efficacy of Fortiva Porcine Dermis versus Strattice Reconstructive Tissue Matrix in 120 patients with large complex abdominal wall ventral hernias undergoing single stage repair. The patient will be blinded to treatment as well as an independent qualified evaluator to confirm evidence of reoccurrence. This post-market study compares two FDA cleared biologic hernia materials. Fortiva™ porcine dermis, processed by RTI Surgical, Inc., a non-cross linked porcine dermis will be compared to Strattice™ Reconstructive Tissue Matrix by Life Cell, a non-cross linked porcine dermis for reinforcement during the single stage open reconstruction of abdominal wall defects. The primary outcome will be hernia recurrence at 1 year. Outcomes will be evaluated at 6 weeks, 3 months, 6 months and 12 months and 24 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Fortiva™ Porcine Dermis | Fortiva Porcine Dermis implantation during repair of complex ventral hernia |
| DEVICE | Strattice™ Reconstructive Tissue Matrix | Strattice tissue matrix implanted during repair of complex ventral hernia |
Timeline
- Start date
- 2015-12-02
- Primary completion
- 2023-09-19
- Completion
- 2023-09-19
- First posted
- 2015-10-27
- Last updated
- 2024-12-27
- Results posted
- 2024-12-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02587403. Inclusion in this directory is not an endorsement.